Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
US7595335B2 · kind B2 · utility
0Cited by
3References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 2004 |
| Grant date | Sep 29, 2009 |
| Priority date | — |
| Expiry date | Apr 5, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition comprising idazoxan or derivatives and their therapeutically acceptable salts, racemates, optically active isomers and polymorphs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.